Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,459,041
-$869,735 QoQ
Shares Held
313,984
0.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#81
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $298,590,573 across 11 Drug Manufacturers - General names. GSK ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
546,930 | $138,903,812 | |
| 2 | MRK |
Merck & Co., Inc.
|
253,643 | $32,593,125 | |
| 3 | AMGN |
Amgen Inc
|
87,964 | $31,853,523 | |
| 4 | ABBV |
AbbVie Inc.
|
108,246 | $27,239,023 | |
| 5 | AZN |
Astrazeneca PLC
|
134,020 | $25,412,872 | |
| 6 | GSK |
GSK plc
This page
|
313,984 | $16,459,041 | |
| 7 | LLY |
ELI LILLY & Co
|
13,666 | $16,391,411 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
66,843 | $3,851,493 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,459,041 | 313,984 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,328,776 | 313,984 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,122,586 | 328,764 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,189,454 | 328,764 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,647,577 | 329,364 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,864,740 | 332,079 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,147,072 | 329,600 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,530,789 | 330,988 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,755,589 | 331,314 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $14,203,431 | 331,314 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,278,496 | 331,314 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,982,437 | 330,550 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,780,802 | 330,550 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,727,168 | 329,600 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,582,144 | 329,600 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,769,582 | 331,960 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,716,052 | 414,952 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,728,433 | 414,956 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,097,258 | 418,402 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $15,785,495 | 421,212 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $18,163,208 | 465,062 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $16,415,898 | 468,962 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $16,967,598 | 470,102 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $19,768,260 | 535,474 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $21,446,141 | 536,062 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $19,921,410 | 536,062 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||